ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
63,081.44
-1.03%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. PharmaCyte Biotech Inc (PMCB) Quote

PharmaCyte Biotech Inc

PharmaCyte Biotech Inc (PMCB)

NASDAQ
2.11
-0.01
(-0.47%)
Closed April 27 4:00PM
Delayed by 15 minutes
2.11
0.00
(0.00%)
After Hours: 4:02PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.11
Bid
2.03
Ask
2.25
Volume
5,644
2.08 Day's Range 2.1199
1.92 52 Week Range 3.23
Market Cap
18.179M
Previous Close
2.12
Open
2.08
Last Trade
43
@
2.1
Last Trade Time
Financial Volume
$ 11,857
VWAP
2.1008
Average Volume (3m)
26,930
Shares Outstanding
8,615,640
Dividend Yield
-
PE Ratio
-4.21
Earnings Per Share (EPS)
-0.5
Revenue
-
Net Profit
-4.32M

About PharmaCyte Biotech Inc

PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technol... PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer killing drugs at the source of cancer. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Medicinal Chems,botanicl Pds
Website
ir.pharmacyte.com
Headquarters
Reno, Nevada, USA
Founded
2018
PharmaCyte Biotech Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PMCB. The last closing price for PharmaCyte Biotech was $2.12. Over the last year, PharmaCyte Biotech shares have traded in a share price range of $ 1.92 to $ 3.23.

PharmaCyte Biotech currently has 8,615,640 shares outstanding. The market capitalization of PharmaCyte Biotech is $18.18 million. PharmaCyte Biotech has a price to earnings ratio (PE ratio) of -4.21.

PMCB Latest News

More News

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

February 14 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

February 06 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

December 15 2023
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

November 28 2023
Edgar (US Regulatory)

Form 8-K - Current report

November 24 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 22 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 22 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 22 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 22 2023
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 22 2023
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.01-0.4716981132082.122.282.077394252.1583658CS
4-0.25-10.5932203392.362.552.07180042.31520383CS
12-0.11-4.954954954952.222.581.94269302.27540291CS
260.052.427184466022.062.581.92213962.24290269CS
52-0.88-29.43143812712.993.231.92286352.61024825CS
156-0.97-31.49350649353.089.981.797751986.05078419CS
260-0.97-31.49350649353.089.981.797751986.05078419CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

PMCB Discussion

View Posts
Fred_Lab Fred_Lab 3 days ago
It seems pretty obvious and unfortunate that whatever resources PMCB has will just be used to support "management" until the money is gone and then they will be gone also. If their technology had any value at all we investors and potential patients would have known something by now. Very sad but true... wishing it were not.
👍️0
$Pistol Pete$ $Pistol Pete$ 1 month ago
Is this scam still alive?
👍️0
longboarder7892 longboarder7892 2 months ago
it should like my p+l is showing huge gains in FEMY. We took in a huge amount of shares under 1.00 and PMCB own close to 13 million shares of FEMY. Looks like all my losses from PMCB are covered already from the move in FEMY. ?So sorry to see PMCB wont be trying to use the product in the cure for PC. For those that hate the old CEO of PMCB karma has come back to him. He is not in good health. whatever goes around comes around. If this helps anyone---
PharmaCyte Biotech Inc. 10% Owner 0f FEMY 12,711,864 shares= as of now thats over a 12 million plus profit

Hey have a great day
👍️0
longboarder7892 longboarder7892 2 months ago
it should like my p+l is showing huge gains in FEMY. We took in a huge amount of shares under 1.00 and PMCB own close to 13 million shares of FEMY. Looks like all my losses from PMCB are covered already from the move in FEMY. ?So sorry to see PMCB wont be trying to use the product in the cure for PC. For those that hate the old CEO of PMCB karma has come back to him. He is not in good health. whatever goes around comes around. If this helps anyone---
PharmaCyte Biotech Inc. 10% Owner 0f FEMY 12,711,864 shares= as of now thats over a 12 million plus profit

Hey have a great day
👍️0
wuniv4ever wuniv4ever 2 months ago
If PMCB bought $5million in (FEMY) and that stock has almost tripled since they did should the charts show something a little different?
👍️0
$Pistol Pete$ $Pistol Pete$ 2 months ago
Scam…..buyers be aware
👍️0
Edward Edward 3 months ago
????? Why would i care.

I haven't owned this stock for many years.

I have no interest in PMCB.
👍️0
Edward Edward 3 months ago
??????????

Why would i care.

I haven't owned this stock for many years.

I have no interest in PMCB.
👍️0
$Pistol Pete$ $Pistol Pete$ 3 months ago
This company is dead
👍️0
$Pistol Pete$ $Pistol Pete$ 5 months ago
Are you still holding this scam?
👍️0
Edward Edward 6 months ago
A 52 week low today.

Expected since they have no product and an unscrupulous;management.
👍️0
$Pistol Pete$ $Pistol Pete$ 7 months ago
Paint job
👍️0
spiritthing spiritthing 7 months ago
Quote up over 20% after hours +++What is happening?
👍️0
$Pistol Pete$ $Pistol Pete$ 7 months ago
$2 is coming
👍️0
Edward Edward 7 months ago
Too funny-- Iroquois say in the s-3/a filing:

"Any proceeds we receive from the exercise of the Warrants will be used for general corporate purpose."

General corporate purposes??? What corporate purposes do they have, there are no operations.

Translation more money to pay themselves and their investment funds holdings to make more money.

They make the former CEO KW look like an angel, and he was a fake, misleading shareholders.
👍️0
joe_techi joe_techi 7 months ago
Risks Associated with Our Business. Our business and our ability to implement our business strategy are subject to numerous risks, mainly in that we don't do anything. If the market recognizes that doing nothing has no value it may negatively impact our share price
👍️0
Edward Edward 7 months ago
NO KIDDING!!!!!!

THAT'S WHY I DO NO NOT OWN ANY SHARES OF PMCB OR HAVE ANY INTENTION TO BUY ANY!!
👍️0
$Pistol Pete$ $Pistol Pete$ 7 months ago
They has zero product and just a shell to sale shares to uneducated people
👍️0
longboarder7892 longboarder7892 7 months ago
The CFO is so busy lol he couldnt file on time-Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
👍️0
joe_techi joe_techi 7 months ago
So much going on with the biz that....Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
👍️0
joe_techi joe_techi 8 months ago
They have authorized more new shares to sell to suckers so they can pay themselves for doing nothing. That is their corporate mission statement
👍️0
Edward Edward 8 months ago
What exactly is management doing at PMCB besides drawing money for fees as directors and as board members-- Answer is nothing.

They can't sell the company since PMCB has an unsaleable product that won't get accepted by the FDA. Any patents or rights are not worth anything since there is no product.

Current Board and Directors are set for a long time getting paid because of the cash .

Take the cash away and the assets are minuscule.
👍️0
$Pistol Pete$ $Pistol Pete$ 8 months ago
Is this scam still alive? I thought it should be delisted by now
👍️0
$Pistol Pete$ $Pistol Pete$ 8 months ago
But now it is still a scam. What take over? Nothing to take over except selling shares and dump into uneducated investors on this scam company
👍️0
longboarder7892 longboarder7892 9 months ago
looks like the takeover will be happen soon. 8-10 dollars would be fine
👍️0
Edward Edward 9 months ago
????????????

I haven't owned this for years!!!!!!!!!
👍️0
$Pistol Pete$ $Pistol Pete$ 9 months ago
$PMCB 100% SELL

https://www.barchart.com/stocks/quotes/PMCB/opinion

Dump and run away from this scam
👍️0
$Pistol Pete$ $Pistol Pete$ 9 months ago
Is this scam still alive? How is the trade for $2.83?
👍️0
$Pistol Pete$ $Pistol Pete$ 9 months ago
Karma to KW. He should be in jail
👍️0
saladan2 saladan2 9 months ago
They sure are crooks.
👍️0
tjclark0551 tjclark0551 9 months ago
Hey Diana,

Thanks for the response. All I can say is Holly Smoke Screen Bat Man they're only pushing hot air. Unbelievable!!!
👍️0
Edward Edward 9 months ago
Yep.

At least KW's Scam was using Pancreatic cancer. Iroquois Scam is for a company that was shut down and doesn't have any operations.And they still increase the authorized shares. LOL.
👍️0
$Pistol Pete$ $Pistol Pete$ 9 months ago
All I can say is “SCAM”
👍️0
Edward Edward 9 months ago
Comical isn't it.

It's for:

the underlying shares of convertible preferred stock and warrants issued by us pursuant to the terms of that certain Securities Purchase Agreement, dated May 9, 2023, by and among PharmaCyte Biotech, Inc. and the investors named therein, in an amount equal to or in excess of 20% of our common stock outstanding before the issuance of such convertible preferred stock and warrants (including any amortization payments made to the holders of convertible preferred stock in the form of issuance of shares of common stock and upon the operation of?anti-dilution provisions contained in such convertible preferred stock and warrants);

https://www.otcmarkets.com/filing/html?id=16722179&guid=1ID-kaPm862pJth


FIRST THEY REDUCE THE OUTSTANDING AND THE ISSUE CONVERTIBLE PREFERRED SHARES AND WARRANTS! TOO FUNNY!
👍️0
$Pistol Pete$ $Pistol Pete$ 9 months ago
Wow….more shares issue so they can dump it again

“to approve a proposed amendment to the PharmaCyte Biotech, Inc. articles of incorporation, as amended, to increase the number of authorized shares of common stock from 133,333,334 to 200,000,000; and”
👍️0
Edward Edward 9 months ago
All operations have been halted on CIAB since Iroquois took over.

There will be no IND.
👍️0
tjclark0551 tjclark0551 9 months ago
Hey, whatever happened with the IND application? I thought PMCB was refining the work and cleaning up the questions asked of them. Haven't been on here for sometime just curious if someone can give an educated guess. Thanks!
👍️0
$Pistol Pete$ $Pistol Pete$ 9 months ago
Swing trader paradise for this scam company
👍️0
$Pistol Pete$ $Pistol Pete$ 9 months ago
He is hiding
👍️0
thenewmixer thenewmixer 10 months ago
wonder where KW is
👍️0
$Pistol Pete$ $Pistol Pete$ 10 months ago
This is a completely scam company
👍️0
Edward Edward 10 months ago
PMCB reduced 48% of the outstanding shares in the tender offer
.
PharmaCyte had 8,708,101 shares of common stock outstanding following payment for the shares of common stock purchased in the tender offer.

And the price still does not go up.

Just shows no one trusts IROQUOIS to head a company. IROQUOIS is only out for themselves. Sice they took over, there is no operations and PMCB is now a shell.

Keep away from any company IROQUOIS controls.
👍️0
$Pistol Pete$ $Pistol Pete$ 10 months ago
Whatever they did, this company is still a scam. Selling shares only and zero product and zero revenue

SCAM
👍️0
longboarder7892 longboarder7892 10 months ago
just got a text that we bought back PMCB. My kid is getting good at this lol maybe my golf game will get better. Tendered the shares and now he bought back in at 2.83 good luck to all that learn how to trade. This was a gift today
👍️0
Edward Edward 10 months ago
PMCM after the tender and the price at currently $2.80 now has a Market Cap of $24.4 million-- TOO FUNNY.

Their cash far exceeds 24.4 million!!!!!

Great job Iroquois.

Even Ken,previous sneaky CEO and Chairman had PMCB at a higher Market cap!

Never own a company that Iroquois has control of!!.
👍️0
longboarder7892 longboarder7892 10 months ago
This is all good for anyone that bought under 2.00 . We did tender our shares close to 100k that we bought from 2.00 and lower and made a huge roi. We will buy again if it goes lower. In the stock market there are those that make money and there are those that watch and wish they did. When the PMCB board decides what they will do the price will be much higher and anyone that watches will still be watching. Have a great weekend its time to go play golf.
👍️0
Edward Edward 10 months ago
Iroquois is taking 8,085,879 shares of the float leaving a little over 9 million in the float, and PMCB is lower by 15 cents since the announcement and 31 cents lower from the offer price.

Correction:

Iroquois is taking 8,085,879 shares of the O/S, leaving a APPOX. 7.6 million float since appox. 15% are held by insiders. PMCB is lower by 15 cents since the announcement and 31 cents lower from the offer price.
👍️0
Edward Edward 10 months ago
Iroquois is taking 8,085,879 shares of the float leaving a little over 9 million in the float, and PMCB is lower by 15 cents since the announcement and 31 cents lower from the offer price.

Says it all what investors think of this joke of a company and the current management.

They will eventually take it private, then they can take all the cash they want for themselves without the SEC or stockholders watching.
👍️0
$Pistol Pete$ $Pistol Pete$ 11 months ago
They both are after their money for sure
👍️0
Edward Edward 11 months ago
Iroquois Capital Management sounds just like the old CEO Ken Waggoner :

From the 14a filed yesterday with the SEC:

Reasons for the Financing



In determining to proceed with the Offer, we considered the ongoing evaluation of our current assets, which are intended to address a highly unmet medical need in pancreatic cancer. Given that we are unable at this point to provide a definitive timeline on when such evaluation will be complete or what the next steps will be following such evaluation,
👍️0

Your Recent History

NASDAQ
PMCB
PharmaCyte Biotech
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved